Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease

被引:61
作者
Kim, Bo-Yeon [1 ]
Jung, Chan-Hee [1 ]
Mok, Ji-Oh [1 ]
Kang, Sung Koo [1 ]
Kim, Chul-Hee [1 ]
机构
[1] Soonchunhyang Univ, Bucheon Hosp, Div Endocrinol & Metab, Dept Internal Med, Puchon, South Korea
来源
JOURNAL OF DIABETES INVESTIGATION | 2014年 / 5卷 / 02期
关键词
Diabetes mellitus type 2; Diabetic angiopathies; Non-alcoholic fatty liver disease; CORONARY-HEART-DISEASE; C-PEPTIDE; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; RISK-FACTORS; EVENTS;
D O I
10.1111/jdi.12139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionThe associations between non-alcoholic fatty liver disease (NAFLD) and chronic vascular complications of type 2 diabetes remain uncertain. We assessed the relationships between NAFLD and chronic vascular complications in patients with type 2 diabetes. Materials and MethodsPatients with type 2 diabetes (n=929) attending a diabetes clinic of a university hospital were studied retrospectively. Patients who had any clinical evidence of cirrhosis or other causes of chronic liver disease were excluded. Prevalences of chronic microvascular and macrovascular complications were assessed. NAFLD was ascertained by ultrasonography. ResultsThe prevalence of NAFLD in patients with type 2 diabetes was 63.3%. The prevalences of diabetic retinopathy and nephropathy were significantly lower in patients with NAFLD than those without NAFLD (33.0 vs 70.2%, P<0.001; 29.3 vs 37.1%, P=0.007, respectively), whereas no difference was found in the prevalence of diabetic neuropathy. The prevalence of diabetic macrovascular complications was lower in type 2 diabetic patients with NAFLD than those without NAFLD (9.2 vs 14.7%, P=0.008). After adjustment for confounding factors, such as age, sex, glycated hemoglobin, fasting serum C-peptide, diabetic duration, body mass index and hypertension, NAFLD remained significantly associated with a lower odds ratio (OR) of diabetic retinopathy (OR 0.440, 95% confidence interval 0.255-0.757, P=0.003) and nephropathy, (OR 0.541, 95% confidence interval 0.358-0.817, P=0.003). In contrast, NAFLD was not significantly associated with macrovascular complications after adjustment for confounding factors. ConclusionsThese results suggest that NAFLD is inversely associated with prevalences of diabetic retinopathy and nephropathy in Korean patients with type 2 diabetes.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 50 条
  • [21] Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease
    Chinnadurai, Rajkumar
    Chrysochou, Constantina
    Kalra, Philip A.
    NEPHRON, 2019, 141 (01) : 24 - 30
  • [22] The Role of Oral Antidiabetic Agents and Incretin Mimetics in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease
    Gouni-Berthold, Ioanna
    Papanas, Nikolaos
    Maltezos, Efstratios
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (22) : 3705 - 3715
  • [23] Non-alcoholic Fatty Liver Disease is an Independent Predictor for Macroangiopathy in Japanese Type 2 Diabetic Patients: A Cross-sectional Study
    Takeuchi, Yuichiro
    Ito, Hiroyuki
    Komatsu, Yuko
    Oshikiri, Koshiro
    Antoku, Shinichi
    Abe, Mariko
    Mifune, Mizuo
    Togane, Michiko
    INTERNAL MEDICINE, 2012, 51 (13) : 1667 - 1675
  • [24] Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy
    Yan, Qianqian
    Zhao, Zihao
    Liu, Dongwei
    Li, Jia
    Pan, Shaokang
    Duan, Jiayu
    Dong, Jiancheng
    Liu, Zhangsuo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients
    Mykhalchyshyn G.
    Kobyliak N.
    Bodnar P.
    Journal of Diabetes & Metabolic Disorders, 14 (1)
  • [26] Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals
    Mantovani, A.
    Zoppini, G.
    Targher, G.
    Golia, G.
    Bonora, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (02) : 215 - 218
  • [27] Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?
    Perdomo, Carolina M.
    Garcia-Fernandez, Nuria
    Escalada, Javier
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [28] Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
    G. Targher
    L. Bertolini
    S. Rodella
    G. Zoppini
    G. Lippi
    C. Day
    M. Muggeo
    Diabetologia, 2008, 51 : 444 - 450
  • [29] Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
    Targher, G.
    Bertolini, L.
    Rodella, S.
    Zoppini, G.
    Lippi, G.
    Day, C.
    Muggeo, M.
    DIABETOLOGIA, 2008, 51 (03) : 444 - 450
  • [30] Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: Just a coincidence?
    G. Targher
    M. Chonchol
    I. Pichiri
    G. Zoppini
    Journal of Endocrinological Investigation, 2011, 34 : 544 - 551